KERALAYURPharmaceuticals
Kerala Ayurveda Ltd — Profit & Loss Statement
₹157.75
-8.80%
Kerala Ayurveda Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.66 Cr | 0.12 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.23 | 0.15 | — |
| Normalized EBITDA | -3.17 Cr | 8.83 Cr | 2.54 Cr | 9.73 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -14.70 Cr | -1.22 Cr | -0.90 Cr | 2.36 Cr | — |
| Reconciled Depreciation | 4.97 Cr | 2.14 Cr | 1.11 Cr | 1.20 Cr | — |
| Reconciled Cost Of Revenue | 22.69 Cr | 21.89 Cr | 20.38 Cr | 17.53 Cr | — |
| EBITDA | -3.17 Cr | 8.83 Cr | 5.37 Cr | 10.53 Cr | — |
| EBIT | -8.15 Cr | 6.69 Cr | 4.26 Cr | 9.32 Cr | — |
| Net Interest Income | -4.09 Cr | -6.04 Cr | -5.12 Cr | -6.41 Cr | — |
| Interest Expense | 4.09 Cr | 6.04 Cr | 4.82 Cr | 6.52 Cr | — |
| Normalized Income | -14.70 Cr | -1.22 Cr | -3.07 Cr | 1.68 Cr | — |
| Net Income From Continuing And Discontinued Operation | -14.70 Cr | -1.22 Cr | -0.90 Cr | 2.36 Cr | — |
| Total Expenses | 130.30 Cr | 96.76 Cr | 88.04 Cr | 70.14 Cr | — |
| Diluted Average Shares | 1.15 Cr | 1.20 Cr | 1.06 Cr | 1.06 Cr | — |
| Basic Average Shares | 1.15 Cr | 1.20 Cr | 1.06 Cr | 1.06 Cr | — |
| Diluted EPS | -12.79 | -0.51 | -0.85 | 2.24 | — |
| Basic EPS | -12.79 | -0.51 | -0.85 | 2.24 | — |
| Diluted NI Availto Com Stockholders | -14.70 Cr | -1.22 Cr | -0.90 Cr | 2.36 Cr | — |
| Net Income Common Stockholders | -14.70 Cr | -1.22 Cr | -0.90 Cr | 2.36 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -14.70 Cr | -1.22 Cr | -0.90 Cr | 2.36 Cr | — |
| Minority Interests | -0.74 Cr | -0.66 Cr | -0.47 Cr | -0.03 Cr | — |
| Net Income Including Noncontrolling Interests | -13.96 Cr | -0.56 Cr | -0.43 Cr | 2.39 Cr | — |
| Net Income Continuous Operations | -13.96 Cr | -0.56 Cr | -0.43 Cr | 2.39 Cr | — |
| Tax Provision | 1.72 Cr | 1.22 Cr | -0.13 Cr | 0.41 Cr | — |
| Pretax Income | -12.24 Cr | 0.66 Cr | -0.56 Cr | 2.80 Cr | — |
| Other Non Operating Income Expenses | 1.82 Cr | 0.30 Cr | 0.21 Cr | 0.09 Cr | — |
| Net Non Operating Interest Income Expense | -4.09 Cr | -6.04 Cr | -5.12 Cr | -6.41 Cr | — |
| Interest Expense Non Operating | 4.09 Cr | 6.04 Cr | 4.82 Cr | 6.52 Cr | — |
| Operating Income | -9.97 Cr | 6.39 Cr | 5.01 Cr | 9.86 Cr | — |
| Operating Expense | 107.61 Cr | 74.87 Cr | 67.66 Cr | 52.61 Cr | — |
| Other Operating Expenses | 48.36 Cr | 38.40 Cr | 17.56 Cr | 13.88 Cr | — |
| Depreciation And Amortization In Income Statement | 4.97 Cr | 2.14 Cr | 1.11 Cr | 1.20 Cr | — |
| Depreciation Income Statement | 4.97 Cr | 2.14 Cr | 1.10 Cr | 1.18 Cr | — |
| Gross Profit | 97.64 Cr | 81.26 Cr | 72.67 Cr | 62.47 Cr | — |
| Cost Of Revenue | 22.69 Cr | 21.89 Cr | 20.38 Cr | 17.53 Cr | — |
| Total Revenue | 120.33 Cr | 103.15 Cr | 93.05 Cr | 80.00 Cr | — |
| Operating Revenue | 120.33 Cr | 103.15 Cr | 93.05 Cr | 80.00 Cr | — |
| Total Unusual Items | — | 0.00 | 2.83 Cr | 0.80 Cr | 0.00 |
| Total Unusual Items Excluding Goodwill | — | 0.00 | 2.83 Cr | 0.80 Cr | 0.00 |
| Interest Income | — | 0.16 Cr | 0.08 Cr | 0.26 Cr | 0.03 Cr |
| Rent Expense Supplemental | — | 4.48 Cr | 3.93 Cr | 3.21 Cr | 2.68 Cr |
| Special Income Charges | — | 0.00 | 2.83 Cr | 0.80 Cr | 0.00 |
| Total Other Finance Cost | — | 0.19 Cr | 0.37 Cr | 0.15 Cr | 0.09 Cr |
| Interest Income Non Operating | — | 0.16 Cr | 0.08 Cr | 0.26 Cr | 0.03 Cr |
| Amortization | — | 0.07 Cr | 72000.00 | 0.02 Cr | 0.10 Cr |
| Research And Development | — | 0.76 Cr | 0.36 Cr | 0.12 Cr | 0.07 Cr |
| Selling General And Administration | — | 17.65 Cr | 16.89 Cr | 12.20 Cr | 9.47 Cr |
| Selling And Marketing Expense | — | 10.58 Cr | 10.65 Cr | 7.27 Cr | 5.85 Cr |
| General And Administrative Expense | — | 7.06 Cr | 6.24 Cr | 4.93 Cr | 3.62 Cr |
| Rent And Landing Fees | — | 4.48 Cr | 3.93 Cr | 3.21 Cr | 2.68 Cr |
| Other Special Charges | — | — | -2.83 Cr | -0.80 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kerala Ayurveda Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.